BR112012000380A2 - diagnóstico e tratamento de doenças autoimunes desmielinizante. - Google Patents
diagnóstico e tratamento de doenças autoimunes desmielinizante.Info
- Publication number
- BR112012000380A2 BR112012000380A2 BR112012000380A BR112012000380A BR112012000380A2 BR 112012000380 A2 BR112012000380 A2 BR 112012000380A2 BR 112012000380 A BR112012000380 A BR 112012000380A BR 112012000380 A BR112012000380 A BR 112012000380A BR 112012000380 A2 BR112012000380 A2 BR 112012000380A2
- Authority
- BR
- Brazil
- Prior art keywords
- diagnosis
- treatment
- autoimmune diseases
- demyelinating autoimmune
- demyelinating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22351109P | 2009-07-07 | 2009-07-07 | |
| PCT/US2010/040992 WO2011005715A1 (en) | 2009-07-07 | 2010-07-02 | Diagnosis and treatment of autoimmune demyelinating diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012000380A2 true BR112012000380A2 (pt) | 2017-02-07 |
Family
ID=42730512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012000380A BR112012000380A2 (pt) | 2009-07-07 | 2010-07-02 | diagnóstico e tratamento de doenças autoimunes desmielinizante. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120128698A1 (pt) |
| EP (1) | EP2451843A1 (pt) |
| JP (1) | JP2012532873A (pt) |
| KR (1) | KR20120051002A (pt) |
| CN (1) | CN102471381A (pt) |
| AU (1) | AU2010270761A1 (pt) |
| BR (1) | BR112012000380A2 (pt) |
| CA (1) | CA2766737A1 (pt) |
| IL (1) | IL217133A0 (pt) |
| MX (1) | MX2012000417A (pt) |
| SG (1) | SG177580A1 (pt) |
| WO (1) | WO2011005715A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10794801B2 (en) | 2013-05-13 | 2020-10-06 | Konica Minolta, Inc. | Cell staining method and sample collection tube used for the same |
| US11299750B2 (en) | 2016-02-03 | 2022-04-12 | Director-General Of National Institute Of Infectious Diseases | Cultured transgenic cell allowing growth of norovirus, and use thereof |
| WO2018094460A1 (en) * | 2016-11-22 | 2018-05-31 | Dendrocyte Biotech Pty Ltd | Anti-cd300f antibody and uses thereof |
| US20180252712A1 (en) * | 2017-03-01 | 2018-09-06 | Washington University | Receptor for norovirus and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5567610A (en) | 1986-09-04 | 1996-10-22 | Bioinvent International Ab | Method of producing human monoclonal antibodies and kit therefor |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DK0479909T3 (da) | 1989-06-29 | 1997-04-07 | Medarex Inc | Bispecifikke reagenser til AIDS-behandling |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5229275A (en) | 1990-04-26 | 1993-07-20 | Akzo N.V. | In-vitro method for producing antigen-specific human monoclonal antibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Ｈｉｖ感染治療のための異種複合抗体 |
| LU91067I2 (fr) | 1991-06-14 | 2004-04-02 | Genentech Inc | Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines |
| US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
| US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| CA2122732C (en) | 1991-11-25 | 2008-04-08 | Marc D. Whitlow | Multivalent antigen-binding proteins |
| ATE503496T1 (de) | 1992-02-06 | 2011-04-15 | Novartis Vaccines & Diagnostic | Biosynthetisches bindeprotein für tumormarker |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
-
2010
- 2010-07-02 WO PCT/US2010/040992 patent/WO2011005715A1/en active Application Filing
- 2010-07-02 US US13/381,304 patent/US20120128698A1/en not_active Abandoned
- 2010-07-02 JP JP2012519635A patent/JP2012532873A/ja active Pending
- 2010-07-02 EP EP10731887A patent/EP2451843A1/en not_active Withdrawn
- 2010-07-02 SG SG2012001558A patent/SG177580A1/en unknown
- 2010-07-02 AU AU2010270761A patent/AU2010270761A1/en not_active Abandoned
- 2010-07-02 MX MX2012000417A patent/MX2012000417A/es not_active Application Discontinuation
- 2010-07-02 CN CN2010800305620A patent/CN102471381A/zh active Pending
- 2010-07-02 KR KR1020127003160A patent/KR20120051002A/ko not_active Application Discontinuation
- 2010-07-02 BR BR112012000380A patent/BR112012000380A2/pt not_active IP Right Cessation
- 2010-07-02 CA CA2766737A patent/CA2766737A1/en not_active Abandoned
-
2011
- 2011-12-22 IL IL217133A patent/IL217133A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2451843A1 (en) | 2012-05-16 |
| IL217133A0 (en) | 2012-02-29 |
| CN102471381A (zh) | 2012-05-23 |
| AU2010270761A1 (en) | 2012-01-19 |
| SG177580A1 (en) | 2012-03-29 |
| CA2766737A1 (en) | 2011-01-13 |
| JP2012532873A (ja) | 2012-12-20 |
| MX2012000417A (es) | 2012-02-08 |
| KR20120051002A (ko) | 2012-05-21 |
| WO2011005715A1 (en) | 2011-01-13 |
| US20120128698A1 (en) | 2012-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2435432I2 (lt) | Apoptozę sukeliantys agentai, skirti vėžio ir imuninių ir autoimuninių ligų gydymui | |
| BR112012002124A2 (pt) | tratamento da doença de crohn com laquinimode. | |
| EP2558493A4 (en) | ANTIBODIES FOR THE TREATMENT OF INFECTION AND DISEASE ASSOCIATED WITH DIFFICULT CLOSTRIDIUM | |
| BRPI0814624A2 (pt) | Tratamento de doença neurodegenerativa progresiva com ibudilaste | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| IT1391555B1 (it) | Apparato trattamento extracorporeo sangue | |
| BR112012002571A2 (pt) | tratamento de minérios de titânio | |
| EP2498796A4 (en) | TREATMENT OF HEART DISEASES | |
| BRPI0917567A2 (pt) | tratamento de doença respiratória | |
| HK1169455A1 (zh) | 阿爾茨海默病的診斷和治療 | |
| ZA201301601B (en) | Treatment of diseases | |
| EP2613786A4 (en) | TREATMENT OF DISEASES | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| GB0908193D0 (en) | Treatment of disease state | |
| GB0922085D0 (en) | Cancer diagnosis and treatment | |
| DK2627345T3 (da) | Formuleringer til behandling af sygdomme i de øvre luftveje | |
| SMT201600189B (it) | Soluzione acquosa comprendente 3-chinuclidinoni per il trattamento di malattie iperproliferative, autoimmuni e cardiache | |
| EP2548888A4 (en) | SPECIFIC PEPTIDE OF PERIODONTAL PATHOLOGY AND TREATMENT AND DIAGNOSIS OF PERIODONTAL PATHOLOGY INCLUDING | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| BRPI0908719A2 (pt) | Metodos de diagnóstico, prevenção e tratamento de doenças de massa óssea | |
| EP2563395A4 (en) | TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES | |
| DE102009018133A8 (de) | Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen | |
| BR112012000380A2 (pt) | diagnóstico e tratamento de doenças autoimunes desmielinizante. | |
| EP2420515A4 (en) | DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-TMPRSS11E ANTIBODY | |
| BRPI1010121A2 (pt) | método de tratamento biológico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |